pharmaceutical lawsuit

Orphan drug affects eyesight Having been widely prescribed for decades, the Elmiron bladder medication has recently been found to be toxic to the retina (damage). An article published by the American Academy of Ophthalmology in 2018 described six patients experiencing pigmentary maculopathy after chronic exposure to Elmiron (pentosan polysulfate sodium) for interstitial cystitis. The following…Read the article

After government inspectors found traces of a cancer-causing chemical in Metformin, the Food and Drug Administration ordered a recall of one of the most commonly-prescribed diabetes drugs in America. FDA officials discovered a dangerous chemical, N-Nitrosodimethylamine, in five different Metformin versions. About 34 million Americans have Type 2 Diabetes, and many of them take some…Read the article

In 2012, the FDA approved the first new prescription weight loss drug in thirteen years: lorcaserin, marketed as Belviq. Available to patients in the US since June 2013 in a twice-daily dose, it was soon (2016) followed by once-a-day Belviq XR. Expectations crushed Nevertheless, this herald of hope for almost one third of Americans rated…Read the article

Heartburn Heaven As recently as August 2019, the ranitidine market was tipped to top a gut-gripping US$ 485.4 million by 2026. Introduced in 1981, this popular antacid – better known as Zantac – was the world’s top-selling prescription drug just six years later. In fact, sweetening the world’s sour stomachs proved a bottomless well of…Read the article

Pharmaceutical giant Johnson & Johnson raised the proverbial white flag, at least to an extent, when it said it would no longer sell its controversial baby powder in the United States and Canada. “Demand for talc-based Johnson’s Baby Powder in North America has been declining due in large part to changes in consumer habits and…Read the article

Recent evidence links the popular heartburn medication to an increased cancer risk, thus FDA demands Zantac recall. The agency wants all ranitidine off store shelves effective immediately. Currently, the Food and Drug Administration is sending letters to Sanofi and other ranitidine manufactures asking them to stop making and shipping product. Additionally, the FDA advises consumers…Read the article

Over-the-counter Zantac (Ranitidine) is already one of the largest-selling antacids in the United States. Annual revenue exceeds $125 million. That market share was expected to triple by 2026. Then, the Food and Drug Administration found a dangerously-high level of a cancer-causing compound in Zantac. The watchdog then ordered Sanofi to stop selling the drug in…Read the article

A Philadelphia jury ordered Johnson & Johnson subsidiary Janssen Pharmaceuticals to pay $8 billion in a drug-induced gynecomastia matter.  26-year-old Nicholas Murray developed abnormally large breasts in 2003. He had been taking Risperdal, an antipsychotic drug, to control his autism spectrum disorder symptoms. In a statement, J&J said it would appeal the “grossly disproportionate” award.…Read the article

The U.S. Food and Drug Administration’s voluntary blood pressure drug recall continues as Torrent Pharmaceuticals Limited announced it is expanding its nationwide recall to include two blood pressure medications that were found to contain trace amounts of a potential cancer-causing carcinogen. The two medications are 3 lots of Losartan Potassium Tablets USP and 2 lots…Read the article

You Are What You Eat High sodium and low potassium diets may contribute to teenage depression, according to a new study. This finding may impact both patients and providers. Such a diet indicates many processed foods and few fresh fruits and vegetables. Researchers at the University of Alabama-Birmingham found a conclusive link between depression and…Read the article